Clinical Trial: Heart Rate Reducing Therapy in Cardiac CT Using Ivabradine and Bisoprolol

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Heart Rate Reducing Therapy With Ivabradine and Bisoprolol Before Coronary Computer Tomographic Angiography in Ambulant Patients

Brief Summary:

Out-patients scheduled for coronary computer tomographic angiography (CCTA) were screened regarding there baseline heart rate. If heart rate was > 75, patients were pretreated with 10mg bisoprolol (group 1) or 10mg bisoprolol plus 7.5mg ivabradine (group 2) to reduce heart rate one our before CCTA was performed.

Heart rate, additional use of i.v. bradycardic agents, motion artefacts, radiation dose and drug tolerance was monitored.

Detailed Summary:

Aim of the study is to evaluate if ivabradine, an inhibitor of the funny channel (If), in addition to bisoprolol is effective in lowering heart rate before coronary computer tomographic angiography (CCTA) if administered orally one hour before the scan.

Out-patients of a single radiology center are included in this retrospective analysis. All patients are referred to an ambulant CCTA. All scans are performed with a Siemens Somatom Sensation Cardiac 64 Computer Tomograph and analyzed with Siemens Syngo Plaza software. Patients with an initial heart rate of ≥ 75 bpm are either pretreated with bisoprolol 10mg p.o. alone (group 1) or a combination of bisoprolol 10mg and ivabradine 7.5mg p.o. (group 2) one hour before the CT scan.

Additional betablocker is administered intravenously right before the scan if heart rate remains elevated.

The hypothesis is that the addition of ivabradine to bisoprolol results in a pronounced heart rate reduction. This heart rate reduction will lead to a reduced need of i.v. bradicardic drug use, a reduction in motion artifacts and a reduced radiation dose to to a higher rate of flash sequences.

Sponsor: Medical University of Graz

Current Primary Outcome: heart rate [ Time Frame: intraoperative ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

• use of i.v. betablockers [ Time Frame: baseline ]
  measured in mg metoprolol
• radiation dose [ Time Frame: intraoperative ]
  as calculated in mSv
• motion artifacts [ Time Frame: intraoperative ]
  Counted linear misalignments in the ap projection

Original Secondary Outcome: Same as current

Information By: Medical University of Graz

Dates:
Date Received: March 15, 2016
Date Started: February 2015
Date Completion:
Last Updated: May 4, 2016
Last Verified: May 2016